SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects
Clinical trial NCT05268198 · COMPLETED
Trial details
- NCT number
- NCT05268198
- Sponsor
- Global Health Drug Discovery Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2023-06-29
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.